R3i
Membership Organizations · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Picassoplatz 8, Basel, Basel-City, 4010,...Website
www.r3i.orgRevenue
$7.6 MillionIndustry
About R3i
R3i Org Chart
Is R3i your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at R3i
Check out if R3i is spiking on competitors!
Check if R3i has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on R3i recently announced quarterly report
Click to see if R3i had a recent Job posting/layoffs
Funding: Get notified immidiatlly once R3i has new funding data
R3i, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when R3i launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
R3i is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
R3i is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about R3i.
R3i Tech Stack
A closer look at the technologies used by R3i
R3i News & Media
International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk
MILAN and BASEL, Switzerland, Sept. 2, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients,...
Top Membership Organizations Companies
Frequently Asked Questions Regarding R3i
The R3i Foundation is a multidisciplinary non-profit organization focused on reducing residual vascular risk associated with macrovascular and microvascular complications. It provides healthcare professionals with evidence-based resources, clinical trials, and expert education to enhance patient outcomes. The foundation aims to support patients who... Read More